The North America Antifreeze Protein Market is expected to witness market growth of 25.4% CAGR during the forecast period (2022-2028).
Antifreeze proteins (AFPs) are biological antifreeze molecules discovered in polar fish for the first time. AFPs can adhere to ice and hence hinder the formation of ice crystals. AFPs allow fish to live in ice-covered or cold waters below the freezing point (0.7 °C) of the blood serum. In a literal sense, however, the word AFP is a misnomer because AFP does not prevent the freezing of blood serum or AFP-containing solutions. As a result, the term ice-binding protein (IBP) was coined to refer to any protein that binds to ice, including AFPs. The ice structuring protein (ISP), which isn't commonly used, is interchangeable with AFP. AFPs, on the other hand, are a subset of IBPs, which also contain ice-nucleating proteins. In other words, while all AFPs are IBPs, not all IBPs are AFPs.
To fulfill the growing demand for frozen meals and vaccines, key firms are focused on R&D and investigating commercial uses in food and medical. Several businesses are aiming to expand and introduce premium salmon salad items to the market. When water freezes, it produces a large number of embryonic ice crystals. These crystals develop and unite to produce an ice block that is visible to the naked eye. Antifreeze protein (AFP) can attach to embryonic ice crystals and prevent them from forming ice blocks.
The regional government is putting sincere efforts into bringing new programs in order to increase the fertility rate within the regional population. The Analytical and Surface Chemistry Program is to observe interactions between specialized antifreeze proteins (AFPs) and ice utilizing fluorescence microscopy techniques combined with a unique ice growth/flow microfluidic cell, due to co-funding from the Division of Molecular and Cellular Biosciences, the Office of International Science and Engineering, and the Office of Polar Programs.
The US market dominated the North America Antifreeze Protein Market by Country 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $5,905.1 Thousands by 2028. The Canada market is anticipated to grow at a CAGR of 28.2% during (2022-2028). Additionally, The Mexico market is expected to showcase a CAGR of 27.1% during (2022-2028).
Based on Type, the market is segmented into Type I, Type III, Antifreeze Glycoprotein, and Others. Based on Form, the market is segmented into Solid and Liquid. Based on Source, the market is segmented into Fish and Others. Based on End-use, the market is segmented into Medical, Food, Cosmetics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kaneka Corporation, Unilever PLC, Nichirei Corporation, A/F Protein Canada Inc., Sirona Biochem, Protokinetix, Inc., Shanghai Yu Tao Industrial Co., Ltd., Kodera herb garden co., ltd., Rishon Biochem Co., Ltd., and Mybiosource, Inc.
By Type
Antifreeze proteins (AFPs) are biological antifreeze molecules discovered in polar fish for the first time. AFPs can adhere to ice and hence hinder the formation of ice crystals. AFPs allow fish to live in ice-covered or cold waters below the freezing point (0.7 °C) of the blood serum. In a literal sense, however, the word AFP is a misnomer because AFP does not prevent the freezing of blood serum or AFP-containing solutions. As a result, the term ice-binding protein (IBP) was coined to refer to any protein that binds to ice, including AFPs. The ice structuring protein (ISP), which isn't commonly used, is interchangeable with AFP. AFPs, on the other hand, are a subset of IBPs, which also contain ice-nucleating proteins. In other words, while all AFPs are IBPs, not all IBPs are AFPs.
To fulfill the growing demand for frozen meals and vaccines, key firms are focused on R&D and investigating commercial uses in food and medical. Several businesses are aiming to expand and introduce premium salmon salad items to the market. When water freezes, it produces a large number of embryonic ice crystals. These crystals develop and unite to produce an ice block that is visible to the naked eye. Antifreeze protein (AFP) can attach to embryonic ice crystals and prevent them from forming ice blocks.
The regional government is putting sincere efforts into bringing new programs in order to increase the fertility rate within the regional population. The Analytical and Surface Chemistry Program is to observe interactions between specialized antifreeze proteins (AFPs) and ice utilizing fluorescence microscopy techniques combined with a unique ice growth/flow microfluidic cell, due to co-funding from the Division of Molecular and Cellular Biosciences, the Office of International Science and Engineering, and the Office of Polar Programs.
The US market dominated the North America Antifreeze Protein Market by Country 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $5,905.1 Thousands by 2028. The Canada market is anticipated to grow at a CAGR of 28.2% during (2022-2028). Additionally, The Mexico market is expected to showcase a CAGR of 27.1% during (2022-2028).
Based on Type, the market is segmented into Type I, Type III, Antifreeze Glycoprotein, and Others. Based on Form, the market is segmented into Solid and Liquid. Based on Source, the market is segmented into Fish and Others. Based on End-use, the market is segmented into Medical, Food, Cosmetics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kaneka Corporation, Unilever PLC, Nichirei Corporation, A/F Protein Canada Inc., Sirona Biochem, Protokinetix, Inc., Shanghai Yu Tao Industrial Co., Ltd., Kodera herb garden co., ltd., Rishon Biochem Co., Ltd., and Mybiosource, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Type I
- Type III
- Antifreeze Glycoprotein
- Others
- Solid
- Liquid
- Fish
- Others
- Medical
- Food
- Cosmetics
- Others
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Kaneka Corporation
- Unilever PLC
- Nichirei Corporation
- A/F Protein Canada Inc.
- Sirona Biochem
- Protokinetix, Inc.
- Shanghai Yu Tao Industrial Co., Ltd.
- Kodera herb garden co., ltd.
- Rishon biochem co., ltd
- Mybiosource, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Antifreeze Protein Market by Type
Chapter 4. North America Antifreeze Protein Market by Form
Chapter 5. North America Antifreeze Protein Market by Source
Chapter 6. North America Antifreeze Protein Market by End-use
Chapter 7. North America Antifreeze Protein Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Kaneka Corporation
- Unilever PLC
- Nichirei Corporation
- A/F Protein Canada Inc.
- Sirona Biochem
- Protokinetix, Inc.
- Shanghai Yu Tao Industrial Co., Ltd.
- Kodera herb garden co., ltd.
- Rishon biochem co., ltd
- Mybiosource, Inc.
Methodology
LOADING...
